J9196 Gemcitabine HCl (ACCORD) - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Gemcitabine HCl (ACCORD)

Brand Name:

Gemcitabine

Strength:

200MG

HCPCS:

J9196

SEER*Rx Category:

Chemotherapy

Major Drug Class:

Antimetabolite

Minor Drug Class:

Pyrimidine Analog

Oral (Y/N):

No

FDA Approval Year:

2011

FDA Discontinuation Year:

CMS Effective Date:

March 17, 2023

CMS Discontinuation Date:

Status:

In Use